title: Effects of general anesthetics on the bacterial luciferase enzyme from Vibrio harveyi: an anesthetic target site with differential sensitivity.
abstract: The effects of a diverse range of 36 general anesthetics and anesthetic-like compounds on a highly purified preparation of the bacterial luciferase enzyme from Vibrio harveyi have been investigated. Under conditions where the flavin site was saturated, almost all of the anesthetics inhibited the peak enzyme activity and slowed the rate of decay. However, a small number of the more polar agents only inhibited at high concentrations, while stimulating activity at lower concentrations. The inhibition was found to be competitive in nature, with the anesthetics acting by competing for the binding of the aldehyde substrate n-decanal. The anesthetic binding site on the enzyme could accommodate only a single molecule of a large anesthetic but more than one molecule of a small anesthetic, consistent with the site having circumscribed dimensions. The homologous series of n-alcohols and n-alkanes exhibited cutoffs in inhibitory potency, but these cutoffs occurred at very different chain lengths (about C10 for the n-alkanes and C15 for the n-alcohols), mimicking similar cutoffs observed for general anesthetic potencies in animals. Binding constants determined from peak height measurements showed that the inhibitor binding site was predominantly hydrophobic (with a mean delta delta G CH2 of -5.0 kJ/mol), but fluctuations in the binding constants with chain length revealed regions in the binding site with polar characteristics. Binding constants to an intermediate form of the enzyme (intermediate II) were also determined, and these confirmed the principal features of the binding site deduced from the peak height measurements. The long-chain compounds, however, bound considerably tighter to the intermediate II form of the enzyme, and this was shown to account for the biphasic decay kinetics that were observed with these compounds. Overall, there was poor agreement between the EC50 concentrations for inhibiting the luciferase enzyme from V. harveyi and those which induce general anesthesia in animals, with bulky compounds being much less potent, and moderately long chain alcohols being much more potent, as luciferase inhibitors than as general anesthetics.
authors.affiliation: Biophysics Section, Blackett Laboratory, Imperial College of Science, Technology, and Medicine, London, U.K.
authors.forename: S
authors.initials: S
authors.lastname: Curry
authors.forename: W R
authors.initials: WR
authors.lastname: Lieb
authors.forename: N P
authors.initials: NP
authors.lastname: Franks
mesh_terms: D000438:Alcohols / Q000494:pharmacology; D000473:Alkanes / Q000494:pharmacology; D000777:Anesthetics / Q000494:pharmacology*; D001665:Binding Sites; D001667:Binding, Competitive; D007700:Kinetics; D008156:Luciferases / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D014733:Vibrio / Q000201:enzymology
chemical_list: D000438:Alcohols; D000473:Alkanes; D000777:Anesthetics; D008156:Luciferases